The expression specific for tumour cells and CD8+ T cells estimated using RESPECTEx were in broad agreement with mean expression levels in MKI67+ single cells (for tumour) and CD8A+ single cells (for CD8+ T cells) (Figure 4D), confirming the validity of inferences by the RESPECTEx pipeline. This evidence concerns the gene CD8A and neoplasm.